Sign in

Optimal Enrollment in Late-Stage New Drug Development with Learning of Drug's Efficacy for Group-Sequential Clinical Trials.

Zhili TianGordon B. HazenHong Li
Published in: Manuf. Serv. Oper. Manag. (2023)
Keyphrases